ABBVIE (4AB BE) stock market data APIs
€162.6367
0.79(0.5%)
as of July 18, 2025
Try our APIs with
free plan!
ABBVIE Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for 4AB.BE.
Prev. Close
162.6367
Open
163.4265
High
163.4265
Low
162.0289
52 wk Range
145.6189-200.2506
Market Cap
196 410 M
Dividends (Yield)
0.0457
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ABBVIE data using free add-ons & libraries
Get ABBVIE Fundamental Data
ABBVIE Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ABBVIE News
New
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of th...
AbbVie Inc. (NYSE:ABBV) is favoured by institutional owners who hold 75% of the company
Key Insights Given the large stake in the stock by institutions, AbbVie's stock price might be vulnerable to their trading decisions A total of 25 investors have a majority stake in the company with ...
AbbVie (ABBV) Surpasses Market Returns: Some Facts Worth Knowing
AbbVie (ABBV) closed at $190.58 in the latest trading session, marking a +2.25% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.32% for the day. Meanwhile, the Do...
How Will AbbVie's Oncology Drugs Aid Upcoming Q2 Results?
AbbVie ABBV has been expanding its oncology portfolio over the past few years. While the company was originally focused on two blood-cancer drugs — Imbruvica and Venclexta — it has since built a b...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
